Foff Erin Pennock
Chief Medical Officer
Sale
Calculated transaction value
$124.07K
15,355 shares @ $8.08
Traded
Oct 15, 2026
Filed
Oct 16, 2026
You're reading the free version. Trader adds the live tape and alerts.
Start tracking
MapLight Therapeutics
MPLT
ManufacturingChemicals
Transactions reported in official disclosures
Price with disclosed trades
Daily closes, past year · marks sit on transaction dates, sized by value
79 trades
| Reporting person | Filed | Transaction | Transaction value | Source | Actions |
|---|---|---|---|---|---|
| Foff Erin Pennock Chief Medical Officer | Oct 16, 2026 1-day lag | Sale Oct 15, 2026 | $124.07K Filed shares x price | SEC Form 4 View filing | |
| Gillis Jonathan CAO And Interim CFO | Oct 16, 2026 1-day lag | Sale Oct 15, 2026 | $82.15K Filed shares x price | SEC Form 4 View filing | |
| Hanson Kristopher General Counsel | Oct 16, 2026 1-day lag | Sale Oct 15, 2026 | $72.88K Filed shares x price | SEC Form 4 View filing | |
| Lillie James Woodruff Chief Scientific Officer | Oct 16, 2026 1-day lag | Sale Oct 15, 2026 | $93.03K Filed shares x price | SEC Form 4 View filing | |
| Kroeger Christopher A. Chief Executive Officer | Oct 16, 2026 1-day lag | Sale Oct 15, 2026 | $595.42K Filed shares x price | SEC Form 4 View filing | |
| Kreitzer Anatol Chief Discovery Officer | Oct 16, 2026 1-day lag | Sale Oct 15, 2026 | $96.02K Filed shares x price | SEC Form 4 View filing | |
| Hanson Kristopher General Counsel | Sep 18, 2026 2-day lag | Sale Sep 16, 2026 | $192.66K Filed shares x price | SEC Form 4 View filing | |
| Kreitzer Anatol Chief Discovery Officer | Aug 19, 2026 2-day lag | Award Aug 17, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Kreitzer Anatol Chief Discovery Officer | Aug 19, 2026 2-day lag | Award Aug 17, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Gillis Jonathan CAO And Interim CFO | Aug 19, 2026 2-day lag | Award Aug 17, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Gillis Jonathan CAO And Interim CFO | Aug 19, 2026 2-day lag | Award Aug 17, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Gillis Jonathan CAO And Interim CFO | Aug 19, 2026 2-day lag | Award Aug 17, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Gillis Jonathan CAO And Interim CFO | Aug 19, 2026 2-day lag | Award Aug 17, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Lillie James Woodruff Chief Scientific Officer | Aug 19, 2026 2-day lag | Award Aug 17, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Lillie James Woodruff Chief Scientific Officer | Aug 19, 2026 2-day lag | Award Aug 17, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Hanson Kristopher General Counsel | Aug 19, 2026 2-day lag | Award Aug 17, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Hanson Kristopher General Counsel | Aug 19, 2026 2-day lag | Award Aug 17, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Foff Erin Pennock Chief Medical Officer | Aug 19, 2026 2-day lag | Award Aug 17, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Foff Erin Pennock Chief Medical Officer | Aug 19, 2026 2-day lag | Award Aug 17, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Kroeger Christopher A. Chief Executive Officer | Aug 19, 2026 2-day lag | Award Aug 17, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Kroeger Christopher A. Chief Executive Officer | Aug 19, 2026 2-day lag | Award Aug 17, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Lillie James Woodruff Chief Scientific Officer | Aug 4, 2026 1-day lag | Sale Aug 3, 2026 | $276.91K Filed shares x price | SEC Form 4 View filing | |
| Cox Troy Director | Jul 28, 2026 Same-day filing | Buy Jul 28, 2026 | $148.7K Filed shares x price | SEC Form 4 View filing | |
| Gillis Jonathan CAO And Interim CFO | Jul 20, 2026 3-day lag | Sale Jul 17, 2026 | $638.2K Filed shares x price | SEC Form 4 View filing | |
| Gillis Jonathan CAO And Interim CFO | Jul 20, 2026 3-day lag | Sale Jul 17, 2026 | $21.91K Filed shares x price | SEC Form 4 View filing | |
| Gillis Jonathan CAO And Interim CFO | Jul 20, 2026 3-day lag | Sale Jul 17, 2026 | $34.35K Filed shares x price | SEC Form 4 View filing | |
| Gillis Jonathan CAO And Interim CFO | Jul 20, 2026 4-day lag | Sale Jul 16, 2026 | $55.26K Filed shares x price | SEC Form 4 View filing | |
| Gillis Jonathan CAO And Interim CFO | Jul 20, 2026 4-day lag | Sale Jul 16, 2026 | $255.85K Filed shares x price | SEC Form 4 View filing | |
| Gillis Jonathan CAO And Interim CFO | Jul 20, 2026 5-day lag | Sale Jul 15, 2026 | $193.51K Filed shares x price | SEC Form 4 View filing | |
| Gillis Jonathan CAO And Interim CFO | Jul 20, 2026 5-day lag | Sale Jul 15, 2026 | $173.58K Filed shares x price | SEC Form 4 View filing |
Gillis Jonathan
CAO And Interim CFO
Sale
Calculated transaction value
$82.15K
10,167 shares @ $8.08
Traded
Oct 15, 2026
Filed
Oct 16, 2026
Hanson Kristopher
General Counsel
Sale
Calculated transaction value
$72.88K
9,020 shares @ $8.08
Traded
Oct 15, 2026
Filed
Oct 16, 2026
Lillie James Woodruff
Chief Scientific Officer
Sale
Calculated transaction value
$93.03K
11,513 shares @ $8.08
Traded
Oct 15, 2026
Filed
Oct 16, 2026
Kroeger Christopher A.
Chief Executive Officer
Sale
Calculated transaction value
$595.42K
73,691 shares @ $8.08
Traded
Oct 15, 2026
Filed
Oct 16, 2026
Kreitzer Anatol
Chief Discovery Officer
Sale
Calculated transaction value
$96.02K
12,248 shares @ $7.84
Traded
Oct 15, 2026
Filed
Oct 16, 2026
Hanson Kristopher
General Counsel
Sale
Calculated transaction value
$192.66K
16,509 shares @ $11.67
Traded
Sep 16, 2026
Filed
Sep 18, 2026
Kreitzer Anatol
Chief Discovery Officer
Award
Calculated transaction value
$0
24,455 shares @ $0
Traded
Aug 17, 2026
Filed
Aug 19, 2026
Kreitzer Anatol
Chief Discovery Officer
Award
Calculated transaction value
$0
6,020 shares @ $0
Traded
Aug 17, 2026
Filed
Aug 19, 2026
Gillis Jonathan
CAO And Interim CFO
Award
Calculated transaction value
$0
2,222 shares @ $0
Traded
Aug 17, 2026
Filed
Aug 19, 2026
Gillis Jonathan
CAO And Interim CFO
Award
Calculated transaction value
$0
2,813 shares @ $0
Traded
Aug 17, 2026
Filed
Aug 19, 2026
Gillis Jonathan
CAO And Interim CFO
Award
Calculated transaction value
$0
6,020 shares @ $0
Traded
Aug 17, 2026
Filed
Aug 19, 2026
Gillis Jonathan
CAO And Interim CFO
Award
Calculated transaction value
$0
24,455 shares @ $0
Traded
Aug 17, 2026
Filed
Aug 19, 2026
Lillie James Woodruff
Chief Scientific Officer
Award
Calculated transaction value
$0
7,730 shares @ $0
Traded
Aug 17, 2026
Filed
Aug 19, 2026
Lillie James Woodruff
Chief Scientific Officer
Award
Calculated transaction value
$0
31,395 shares @ $0
Traded
Aug 17, 2026
Filed
Aug 19, 2026
Hanson Kristopher
General Counsel
Award
Calculated transaction value
$0
7,730 shares @ $0
Traded
Aug 17, 2026
Filed
Aug 19, 2026
Hanson Kristopher
General Counsel
Award
Calculated transaction value
$0
31,395 shares @ $0
Traded
Aug 17, 2026
Filed
Aug 19, 2026
Foff Erin Pennock
Chief Medical Officer
Award
Calculated transaction value
$0
13,360 shares @ $0
Traded
Aug 17, 2026
Filed
Aug 19, 2026
Foff Erin Pennock
Chief Medical Officer
Award
Calculated transaction value
$0
54,240 shares @ $0
Traded
Aug 17, 2026
Filed
Aug 19, 2026
Kroeger Christopher A.
Chief Executive Officer
Award
Calculated transaction value
$0
23,145 shares @ $0
Traded
Aug 17, 2026
Filed
Aug 19, 2026
Kroeger Christopher A.
Chief Executive Officer
Award
Calculated transaction value
$0
93,955 shares @ $0
Traded
Aug 17, 2026
Filed
Aug 19, 2026
Lillie James Woodruff
Chief Scientific Officer
Sale
Calculated transaction value
$276.91K
22,082 shares @ $12.54
Traded
Aug 3, 2026
Filed
Aug 4, 2026
Cox Troy
Director
Buy
Calculated transaction value
$148.7K
15,620 shares @ $9.52
Traded
Jul 28, 2026
Filed
Jul 28, 2026
Gillis Jonathan
CAO And Interim CFO
Sale
Calculated transaction value
$638.2K
16,969 shares @ $37.61
Traded
Jul 17, 2026
Filed
Jul 20, 2026
Gillis Jonathan
CAO And Interim CFO
Sale
Calculated transaction value
$21.91K
600 shares @ $36.51
Traded
Jul 17, 2026
Filed
Jul 20, 2026
Gillis Jonathan
CAO And Interim CFO
Sale
Calculated transaction value
$34.35K
900 shares @ $38.17
Traded
Jul 17, 2026
Filed
Jul 20, 2026
Gillis Jonathan
CAO And Interim CFO
Sale
Calculated transaction value
$55.26K
1,476 shares @ $37.44
Traded
Jul 16, 2026
Filed
Jul 20, 2026
Gillis Jonathan
CAO And Interim CFO
Sale
Calculated transaction value
$255.85K
6,979 shares @ $36.66
Traded
Jul 16, 2026
Filed
Jul 20, 2026
Gillis Jonathan
CAO And Interim CFO
Sale
Calculated transaction value
$193.51K
5,356 shares @ $36.13
Traded
Jul 15, 2026
Filed
Jul 20, 2026
Gillis Jonathan
CAO And Interim CFO
Sale
Calculated transaction value
$173.58K
4,699 shares @ $36.94
Traded
Jul 15, 2026
Filed
Jul 20, 2026